Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 billion) in 2024, it said on ...

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment ...

The PGIM Jennison Focused Growth Fund rose 5.7%, slightly underperforming the Russell 1000 Growth Index. Click here to read ...

Shareholders with any queries in relation to their Novo holding are advised to contact Automic at [email protected] or on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside Australia).

Shareholders with any queries in relation to their Novo holding are advised to contact Automic at [email protected] or on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside ...

SINGAPORE – Ms Pang Gek Teng, who grew Surrey Hills Grocer from one to five outlets, is no longer chief executive (CEO) of Surrey Hills Holdings after it terminated her employment on March 26.

Shareholders with any queries in relation to their Novo holding are advised to contact Automic at ... or on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside Australia). Authorised for ...

Copenhagen, DENMARK — Novo Nordisk defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an "important" weight loss treatment.